I understood from the company that a phase 3 trial of Cavatak and Yervoy would begin by the end of calendar 2018 at the earliest, my guess is that it would take at least 2 years to execute and probably another year to get approval.
If there is a chance of approval based on the in-flight phase 1/2 trial that would be great, but I can't see anyone (credible) saying that will happen.
Ann: Trading Halt, page-69
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)